Home » VALEANT LOSES $2.4M JUDGMENT, REPORTS SECOND-QUARTER LOSS
VALEANT LOSES $2.4M JUDGMENT, REPORTS SECOND-QUARTER LOSS
A California court has issued a $2.4 million judgment in a case brought by Caleel+Hayden against Valeant Pharmaceuticals International, Caleel+Hayden said. The lawsuit in Orange County Superior Court challenged Valeant's termination of a distribution
agreement for Valeant's Kinerease skin care product line. Caleel+Hayden argued
that the contract was wrongfully terminated, and was awarded $2.4 million.
Los
Angeles Business
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May